Kevin Patrick Moran - Jul 28, 2023 Form 4 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Signature
/s/ Kevin Patrick Moran
Stock symbol
VNDA
Transactions as of
Jul 28, 2023
Transactions value $
-$13,945
Form type
4
Date filed
8/1/2023, 04:30 PM
Previous filing
Jun 20, 2023
Next filing
Feb 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNDA Common Stock Sale -$2.6K -412 -0.34% $6.30 123K Jul 28, 2023 Direct F1
transaction VNDA Common Stock Sale -$11.3K -1.8K -1.47% $6.31 121K Jul 28, 2023 Direct F1
holding VNDA Common Stock 635 Jul 28, 2023 By Wife
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.